J Sieber

Summary

Publications

  1. doi Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis
    Jochen Sieber
    Stallergènes GmbH, Kamp Lintfort, Germany
    Curr Med Res Opin 26:925-32. 2010
  2. doi Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates
    J Sieber
    Medical Department, Stallergènes GmbH, Kamp Lintfort, Germany
    Curr Med Res Opin 27:855-61. 2011
  3. ncbi The RHINASTHMA GAV scores without SLIT, at the beginning and at the end of seasonal SLIT
    Jochen Sieber
    Stallergènes, Kamp Lintfort, Germany
    Asian Pac J Allergy Immunol 28:232-6. 2010
  4. doi Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy
    Jochen Sieber
    Stallergènes GmbH, Medical Department, Kamp Lintfort, Germany
    Ann Med 43:418-24. 2011
  5. doi Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: the ECRIT study
    Jochen Sieber
    Stallergènes GmbH, Medical Department, Carl Friedrich Gauss Str 50, 47475 Kamp Lintfort, Germany
    Expert Opin Drug Saf 11:7-13. 2012
  6. doi Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
    H Ott
    Department of Dermatology and Allergology, University Hospital of the Rheinisch Westfälische Technische Hochschule Aachen, Kamp Lintfort, Germany
    Allergy 64:1394-401. 2009

Detail Information

Publications6

  1. doi Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis
    Jochen Sieber
    Stallergènes GmbH, Kamp Lintfort, Germany
    Curr Med Res Opin 26:925-32. 2010
    ..To compare the effectiveness of perennial and co-seasonal high-dose sublingual immunotherapy (SLIT) treatments as well as ultra-rush and classical titrations in a real-world setting for pollen allergens...
  2. doi Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates
    J Sieber
    Medical Department, Stallergènes GmbH, Kamp Lintfort, Germany
    Curr Med Res Opin 27:855-61. 2011
    ....
  3. ncbi The RHINASTHMA GAV scores without SLIT, at the beginning and at the end of seasonal SLIT
    Jochen Sieber
    Stallergènes, Kamp Lintfort, Germany
    Asian Pac J Allergy Immunol 28:232-6. 2010
    ....
  4. doi Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy
    Jochen Sieber
    Stallergènes GmbH, Medical Department, Kamp Lintfort, Germany
    Ann Med 43:418-24. 2011
    ..Conclusion. The effectiveness of sublingual and subcutaneous immunotherapy with pollen extracts appeared virtually equal in daily medical routine. Due to the advantageous safety profile, the sublingual application may be favorable...
  5. doi Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: the ECRIT study
    Jochen Sieber
    Stallergènes GmbH, Medical Department, Carl Friedrich Gauss Str 50, 47475 Kamp Lintfort, Germany
    Expert Opin Drug Saf 11:7-13. 2012
    ..This double-blind, placebo-controlled study evaluated the safety of ultra-rush grass pollen immunotherapy with sublingual drops (Staloral)® in co-seasonal treatment over three consecutive seasons...
  6. doi Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
    H Ott
    Department of Dermatology and Allergology, University Hospital of the Rheinisch Westfälische Technische Hochschule Aachen, Kamp Lintfort, Germany
    Allergy 64:1394-401. 2009
    ..This randomized, double-blind, placebo-controlled study evaluated the efficacy, carry-over effect and safety of grass pollen SLIT using co-seasonal treatment...